Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Teaser Text The Mathematical Institute of Leiden University and the Centre for Mathematical Sciences of Lund University have a position for a PhD candidate to join the project Analysis of Inhomogeneous Wave Euqations under the supervision of
Opportunity:- Policy Research Trainee Organization: European Institute of Policy Research and Human Rights AISBL Location: Remote Duration: 8 weeks About the Opportunity The European Institute of Policy Research and Human Rights is a prestigious institution offering
Opportunity:- Policy Research Trainee Organization: European Institute of Policy Research and Human Rights AISBL Location: Remote Duration: 8 weeks About the Opportunity The European Institute of Policy Research and Human Rights is a prestigious institution offering